PCOD vs PCOS in India: What the Difference Really Means

• PCOS (polycystic ovary syndrome) is the modern, internationally agreed term for the full condition; PCOD (polycystic ovarian disease) is an older Indian term that, in everyday use, often refers only to the ultrasound finding of multiple small follicles.
• They are not two different diseases — they sit along one spectrum. The same biology can earn either label depending on how thorough the work-up was.
• PCOS is diagnosed using the Rotterdam criteria: any 2 of 3 features (irregular ovulation, signs of high androgens, polycystic ovaries on scan), after ruling out other causes.
• The metabolic load of PCOS — insulin resistance, type 2 diabetes risk, fatty liver, heart risk — is the part a vague PCOD label tends to hide, and it is the most important reason to push for the full work-up.
• Most women with PCOS who want to conceive eventually do, and the period, skin and metabolic problems all respond to the same lifestyle-first plan.
• Roughly 1 in 5 reproductive-age Indian women are affected, so this is one of the most common conditions a young woman in India will encounter.

PCOS stands for polycystic ovary syndrome; PCOD stands for polycystic ovarian disease. That last word carries most of the clinical meaning.

A syndrome is a defined cluster of features that travel together and share underlying biology. In PCOS that cluster is irregular ovulation, raised male-pattern hormones (androgens) and polycystic-appearing ovaries on ultrasound, sitting on top of a metabolic spine of insulin resistance. A disease, in the older sense, points to a single organ abnormality — in PCOD, the appearance of many small follicles on the ovary itself, often without the full surrounding picture.

Internationally, and at most modern Indian academic centres, PCOS has replaced PCOD because it captures the hormonal and metabolic whole rather than just the scan. FOGSI (the Federation of Obstetric and Gynaecological Societies of India), the ICMR and endocrine bodies all use PCOS. PCOD lives on in older textbooks, radiology reports, hospital websites and everyday speech — especially outside the metros.

The result is real-world confusion: two women with the same biology can leave two clinics on the same day carrying two different labels. A useful working translation for 2026 India is this — when a report says PCOD, it usually means polycystic-appearing ovaries plus irregular cycles, with the rest of the work-up pending. When it says PCOS, it usually means the full criteria are met and the metabolic tail is being taken seriously. Neither is "wrong," but the second carries more weight.

Most of the world — and FOGSI-aligned Indian practice — diagnoses PCOS using the 2003 Rotterdam criteria. A woman has PCOS when any two of the three features below are present, and other causes (thyroid disease, high prolactin, congenital adrenal hyperplasia, androgen-secreting tumours, Cushing syndrome) have been ruled out.

The three features are:

India carries one of the highest PCOS burdens in the world. Community studies place prevalence at roughly 10 to 25 percent of reproductive-age women, depending on the criteria and population, with urban rates running higher than rural and a clear rise over the last two decades that tracks changing diet, weight, sleep and stress.

A very common Indian scenario goes like this. A woman in her late teens or early twenties sees a gynaecologist or radiology centre for mild irregular periods or acne, gets a pelvic ultrasound, the report says "polycystic-appearing ovaries," and she walks out with PCOD on the prescription. Hormones are not always tested. Metabolic blood work is often skipped. She may be told to lose weight and handed a strip of pills or metformin — and a label that may or may not match the full picture follows her into every future visit.

The mirror image is just as common: a woman with the full PCOS picture — irregular cycles, visible hirsutism, central weight gain, dark velvety neck patches (acanthosis nigricans) — who has never had her fasting glucose, insulin or lipids checked, and has no idea her risk of type 2 diabetes, fatty liver and heart disease is raised and largely modifiable.

The fix in both directions is the same. Whenever a PCOD or PCOS label is given, the right next question is: have the Rotterdam criteria been formally checked, and has the hormonal and metabolic blood work been done?

At the bedside the two labels produce a very similar symptom list — part of why the distinction blurs so easily.

Menstrual irregularity is the dominant complaint in both: cycles every 35–90 days rather than 28–35, frequently missed months, very light periods, or occasional unpredictable heavy bleeds when the lining finally sheds. The underlying mechanism is failed ovulation, and over time it produces the "unopposed estrogen" pattern behind the endometrial risk discussed later.

Skin and hair changes are the next visible cluster. Acne tends to be moderate-to-severe, sits on the jawline, chin and upper back, flares around the cycle and resists the treatments that handle teenage acne well — covered in PCOS acne treatment in India. Hirsutism (coarse dark hair on the upper lip, chin, lower abdomen and back) is one of the more distressing features. Paradoxically, the same androgen excess thins scalp hair at the crown — see PCOS and androgenic hair loss.

Weight tends to gain centrally, around the abdomen, and is consistently harder to shift because of insulin resistance — practical strategies are in weight loss for women with PCOS in India. Acanthosis nigricans — velvety dark patches at the neck, underarms and knuckles — is a low-cost bedside clue to insulin resistance. Subfertility is common but very often treatable. Mood changes — cycle irritability, low mood and a higher background rate of anxiety and depression — are reported in both groups and deserve to be named, not dismissed.

The single sharpest reason to take a PCOS label seriously — rather than treating it as "just irregular periods plus cysts" — is the metabolic spine running beneath it. Insulin resistance, where cells respond poorly to insulin and the pancreas compensates by making more, is present in a high proportion of Indian women with PCOS even when body weight looks normal, and it is the biggest driver of long-term complications.

Type 2 diabetes is the headline downstream risk. Women with PCOS carry a substantially higher lifetime risk than peers of the same age and weight, and that risk starts climbing in the twenties, not midlife. A fasting glucose, HbA1c and an oral glucose tolerance test where indicated belong in the first work-up — read more in type 2 diabetes in Indian women.

Dyslipidemia (raised triglycerides and LDL, low HDL) accompanies the insulin resistance and bridges into higher long-term cardiovascular risk. Non-alcoholic fatty liver disease is now recognised as part of the PCOS metabolic syndrome and shows up on ultrasound at younger ages than once thought. Obstructive sleep apnea runs higher and feeds back into insulin resistance.

Long term, chronic unopposed estrogen from months without ovulation raises the risk of endometrial cancer — the strongest reason to either induce regular withdrawal bleeds with cyclical progestin or use combined pills (when fertility isn't the goal), rather than going many months without a period. Learn the warning signs of endometrial cancer.

None of this is inevitable. The same lifestyle and medication strategies that fix the periods also reverse insulin resistance, lower lipids and reduce fatty liver — and women who name and address the metabolic picture early consistently do best.

The Indian diagnostic pathway is short, stepwise and largely affordable.

1. History and examination. Your doctor asks about age at first period, cycle length and regularity, recent bleeding pattern, weight changes, acne and hair timeline, mood, sleep, family history of PCOS, diabetes and heart disease, and fertility plans. The exam looks for a bulky uterus, any adnexal mass and the dark velvety neck/underarm patches of acanthosis nigricans.

2. Imaging. A transvaginal ultrasound (roughly ₹500–2,500) is first-line in sexually active women; a transabdominal scan is used for young unmarried women. The scan counts follicles per ovary, measures ovarian volume, looks for the classic "string of pearls" pattern and rules out fibroids or a polyp. (For when an ovarian finding does or doesn't matter, see ovarian cysts — types and when to worry and what an enlarged-ovary scan finding means.)

3. Hormone testing, ideally on day 2–5 of a bleed (₹1,500–4,000 in private labs; free or near-free at government teaching hospitals): LH and FSH, total testosterone, SHBG with a calculated free androgen index, DHEAS (adrenal source), prolactin (rules out a prolactinoma), TSH (rules out thyroid disease) and 17-hydroxyprogesterone in selected cases. AMH is often raised in PCOS and is increasingly used as a supportive marker — more on that in AMH and ovarian reserve testing.

4. Metabolic testing — the step most often skipped, and the one where the PCOD-versus-PCOS distinction is sharpest: fasting glucose, fasting insulin (to calculate HOMA-IR), an oral glucose tolerance test where indicated, HbA1c, a lipid profile and liver function (another ₹1,500–3,500). Vitamin D, B12 and ferritin are often added in India because deficiency is common and worsens fatigue and mood.

The combined work-up usually comes to ₹2,000–6,000 at a private lab, is fully covered at government hospitals, and is reimbursable under most health insurance. This is the package that turns a "PCOD on ultrasound" finding into a properly characterised PCOS diagnosis with a plan that matches your actual biology.

Whichever label you carry, lifestyle is the foundation of PCOS care — the only intervention that addresses every part of the syndrome at once. A modest, sustained weight loss of 5 to 10 percent of body weight can restore spontaneous ovulation in a meaningful proportion of women, sharply lowers fasting insulin, and is often enough on its own to bring periods back into rhythm.

Eat a low-glycaemic Indian plate. The single biggest swap is moving your carbohydrate base from refined white rice and maida (white bread, biscuits, instant noodles, packaged snacks) towards whole grains and millets — ragi, bajra, jowar, foxtail millet (thinai), little millet (samai) and hand-pounded or brown rice. Add dal, chana, rajma and sprouts for protein, plenty of leafy greens (palak, methi, drumstick leaves) and seasonal sabzi, curd or buttermilk, and fruit with meals rather than between them. Pull back on processed sugar, sweet drinks and deep-fried snacks rather than banning them — the steady pattern matters more than any perfect week. The fuller plan is in the anti-PCOS diet that actually works.

Move regularly. Aim for 150 minutes a week of moderate aerobic activity (brisk walking, cycling, swimming, dancing) plus two short strength sessions. Measurable drops in insulin resistance and waist size usually appear within 8–12 weeks. Yoga has evidence for small, consistent benefits on cycle regularity and stress in Indian trials.

Protect sleep and manage stress. Seven to nine hours of sleep and a stress practice you'll actually keep (pranayama, meditation, a daily walk) directly modulate the cortisol–insulin axis that drives PCOS.

Two honest notes: weight loss is genuinely harder in PCOS, so aim for steady change over 6–12 months, not crash drops; and lifestyle and medication are partners, not rivals — many women do best on lifestyle plus metformin or a low-dose pill in the first year, then taper the medication as the lifestyle gains hold.

When lifestyle alone isn't enough, the Indian medication ladder is built around three goals: improving insulin sensitivity, regularising the cycle and protecting the endometrium, and treating the visible androgenic features. Most women use one or two rungs at a time, and the mix changes over the years.

Metformin sits at the base, targeting insulin resistance. A typical start is 500 mg once daily with the largest meal, built up over 2–4 weeks to 500–1,000 mg twice daily to limit gut side effects (loose stools, nausea, metallic taste) that usually settle within a month. It improves cycle regularity, restores ovulation in many women and reduces progression to type 2 diabetes. Cost runs roughly ₹50–300 a month, cheapest at Jan Aushadhi outlets.

Combined oral contraceptive pills are the next rung when the priority is cycle regularity, acne and hirsutism rather than insulin resistance, and they are first-line hormonal therapy for women not currently trying to conceive. Common Indian choices include drospirenone-based pills (anti-androgenic), cyproterone-based pills (short-term for moderate-to-severe hirsutism and acne) and lower-dose options for those who tolerate hormones less well. They give predictable monthly bleeds, lower circulating androgens, clear most acne and hirsutism over 3–6 cycles, and protect the endometrium. Cost: ₹100–500 a month. Contraindications and detail are in the complete guide to the pill and PCOS treatment options in India.

Spironolactone is added when hirsutism stays dominant despite a pill, at 50–200 mg a day, with visible improvement over 6–9 months when paired with cosmetic measures. It must be used with reliable contraception because of potential effects on a male fetus.

For women trying to conceive, ovulation induction with letrozole (2.5–7.5 mg on days 2–6) is now first-line in Indian and international guidelines, with better live-birth rates than older clomiphene citrate, especially at higher BMI. IUI or IVF is the next rung. Full detail is in PCOS fertility treatment. Ovarian drilling and bariatric surgery are reserved for very selected situations and are no longer first-line.

Fertility worry is the single most common reason young Indian women with a PCOD or PCOS label return to the gynae OPD a few years on — and the picture is far more hopeful than early-twenties anxiety suggests. Most women with PCOS who want to conceive eventually do, and the pathway is well-mapped and largely affordable in India.

The first step for many is the same lifestyle work that helps everything else. A 5–10 percent reduction in body weight restores spontaneous ovulation in a meaningful share of overweight women, sometimes within 3–6 months. Even without weight loss, treating insulin resistance and improving sleep can return cycle regularity.

When ovulation doesn't return on its own, ovulation induction is next. Letrozole 2.5–7.5 mg on days 2–6 is first-line and works in a large majority of women, with better live-birth rates than clomiphene citrate (still a reasonable alternative). Cycles are monitored with a follicular-tracking scan around day 10–12 (₹500–1,500 per scan), and most pregnancies in responders happen within the first three to six cycles. Where tablets aren't enough, low-dose gonadotropin injections are added. IUI suits combined-factor couples (≈₹8,000–25,000 per cycle); IVF is the step for non-responders (≈₹1.5–3 lakh per cycle privately, far less at government teaching hospitals).

Two practical points. Ovulation induction carries a small but real risk of ovarian hyperstimulation and multiple pregnancy, which is why cycles are scan-monitored and doses kept conservative. And women with PCOS who conceive have slightly higher rates of gestational diabetes, pregnancy-induced high blood pressure and preterm birth — so a planned pre-pregnancy visit and active glucose monitoring matter. The fuller picture is in PCOS and pregnancy in India.

The best argument for distinguishing PCOS from a vague PCOD label is the size of the long-term complication picture — and how preventable it is when addressed early.

Type 2 diabetes is the headline: a substantially higher lifetime risk than peers of similar age and weight, with the climb starting in the twenties and a meaningful proportion already in the prediabetes range by their thirties. Annual fasting glucose and HbA1c from diagnosis, lifestyle change and metformin where indicated cut this risk substantially — see type 2 diabetes in Indian women.

Cardiovascular disease risk is raised over the lifetime, driven by insulin resistance, raised triglycerides, low HDL, higher blood pressure and central weight. Obstructive sleep apnea runs higher and worsens both. Non-alcoholic fatty liver disease is a frequent companion and reverses reliably with weight loss in its early stages.

Endometrial cancer is the gynaecological cancer most closely tied to PCOS. The mechanism is simple: when ovulation fails for months, the endometrium sees estrogen without the protective monthly shedding that progesterone triggers, and over years that unopposed estrogen can drive hyperplasia and, in some women, cancer. The fix is equally simple — combined pills or cyclical progestin (for example medroxyprogesterone 10 mg for 10 days every 1–3 months) to induce a regular withdrawal bleed in women who go many months without periods. Know the warning signs of endometrial cancer.

Mental health needs the same active management as the physical risks. Depression, anxiety and disordered eating run higher in PCOS, and the body-image impact of hirsutism, acne and weight is real — name it at the consultation. Counselling is part of good PCOS care; see accessing mental-health care for women. The free, confidential iCall helpline (9152987821) is one option for women who want to talk to someone before deciding on therapy.

Many Indian women combine conventional medicine with traditional practice, and the framing matters. Conventional care — lifestyle, metformin, hormonal options, ovulation induction where needed and structured metabolic monitoring — is the foundation with the strongest evidence. Traditional and complementary practices sit alongside it and can genuinely help with stress, sleep, mood and cycle regularity when used responsibly.

Yoga has the strongest evidence of the complementary options. Indian trials show small but consistent improvements in cycle regularity, androgen markers, insulin sensitivity and mood with regular practice. A daily 10–15 minute Surya Namaskar sequence, gentler asanas such as Bhujangasana, Setubandhasana and Baddha Konasana, and pranayama such as Anulom Vilom and Bhramari are commonly used. Frame yoga as a free, sustainable layer on top of the lifestyle plan — not a replacement. (Evidence-based yoga for women's health.)

Ayurveda is widely used in Indian PCOS care, and the evidence is mixed. A few single herbs (such as cinnamon and fenugreek) have small trial evidence for insulin-sensitivity benefit; multi-ingredient PCOS formulations often lack consistent dosing or rigorous trials. The safest approach is to discuss any preparation with both your gynaecologist and Ayurvedic practitioner together, to avoid herb–drug interactions (especially with metformin, the pill and thyroid medication) and to make sure it is added to — never substituted for — conventional care. More in Ayurveda for PCOS.

Two cautions. No traditional or alternative approach reliably reverses PCOS on its own when the metabolic syndrome is present, and waiting for an "alternative cure" while diabetes and heart risk go unaddressed is the commonest way good intentions cause harm. And be wary of rapid "PCOS cure" programmes outside the conventional framework — the evidence for sustained improvement is built on the lifestyle, medication and monitoring pathway above.

Book a gynaecologist or endocrinologist if any of the following apply — and if you already have a PCOD or PCOS label, use the visit to confirm the full work-up has been done.

• Myth: PCOD and PCOS are completely different conditions. Fact: they sit along one spectrum — PCOD in everyday Indian use usually means polycystic-appearing ovaries with milder symptoms, while PCOS describes the full syndrome with hormonal and metabolic features. The right next step in either case is to check whether the Rotterdam criteria are met and complete the blood work.
• Myth: PCOD means the ovaries must be removed. Fact: ovarian removal is not part of PCOS or PCOD care in any modern guideline. The old wedge resection was replaced by laparoscopic ovarian drilling, which itself is now rarely needed because lifestyle, metformin, hormonal options and letrozole address the syndrome more safely.
• Myth: a PCOS diagnosis makes infertility certain. Fact: most Indian women with PCOS who want to conceive eventually do — lifestyle restores ovulation in many, ovulation induction works in the large majority, and IUI or IVF cover most of the rest. PCOS is one of the most treatable causes of subfertility.
• Myth: home remedies or Ayurvedic preparations alone can cure PCOS. Fact: lifestyle is the foundation and traditional practices can genuinely help with stress, sleep and mood, but no preparation reliably reverses the syndrome on its own when the metabolic features are present. The safest plan is conventional care plus complementary practice, used together.
• Myth: marriage or pregnancy cures PCOS. Fact: neither alters the underlying biology. Cycles often improve around childbearing because of pregnancy and breastfeeding hormones, but the syndrome returns once cycles restart and the metabolic risk continues regardless — so don't pause the lifestyle and monitoring plan around either event.
• Myth: type 2 diabetes is inevitable with PCOS. Fact: the lifetime risk is raised but largely modifiable. Sustained 5–10 percent weight loss, regular movement, sleep, stress management and metformin where indicated cut the progression rate substantially — and women who address the metabolic risk early do markedly better.

• World Health Organization — Polycystic ovary syndrome (fact sheet)
• International evidence-based guideline for the assessment and management of PCOS (2023, Monash University / endorsed internationally)
• American College of Obstetricians and Gynecologists (ACOG) — Polycystic Ovary Syndrome (FAQ)
• NHS — Polycystic ovary syndrome (PCOS)
• Indian Council of Medical Research (ICMR) — health research and guidance
• Federation of Obstetric and Gynaecological Societies of India (FOGSI)